Goeltz II Robert C. 4/A
4/A · Arcus Biosciences, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4/AAmended
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Award
Common Stock
2024-01-23+22,000→ 73,831 total
Footnotes (1)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.